5-HYDROXYINDOLACETIC ACID INCREASED

This adverse event was reported 36 times

These drugs are most commonly taken by patients reporting 5-HYDROXYINDOLACETIC ACID INCREASED:

# Drug Count
0 OCTREOTIDE ACETATE 20
1 EVEROLIMUS 9
2 CAPECITABINE 6
3 TEMOZOLOMIDE 6
4 CARBOPLATIN 5
5 ETOPOSIDE 5
6 TELOTRISTAT ETHYL 4
7 WARFARIN 3
8 CALCIUM 2
9 HYDROCHLOROTHIAZIDE 2
See all common drugs associated with 5-HYDROXYINDOLACETIC ACID INCREASED

5-HYDROXYINDOLACETIC ACID INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LUTETIUM LU 177 DOTATATE 1 0.0033
1 OCTREOTIDE ACETATE 20 0.0009
2 TELOTRISTAT ETHYL 4 0.0008
3 PAMIDRONATE DISODIUM 2 0.0007
4 TEMOZOLOMIDE 6 0.0005
5 FOSINOPRIL 1 0.0003
6 EVEROLIMUS 9 0.0002
7 DICLOFENAC SODIUM AND MISOPROSTOL 1 0.0002
8 LOPERAMIDE HCL 1 0.0002
9 ETOPOSIDE 5 0.0001
See all drugs enriched for association with 5-HYDROXYINDOLACETIC ACID INCREASED

5-HYDROXYINDOLACETIC ACID INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 5 0.0001
1 Prostaglandin E1 Analog [EPC] 1 0.0001
2 Aluminum Complex [EPC] 1 0.0001
3 Alkylating Drug [EPC] 6 0.0000
4 Nucleoside Metabolic Inhibitor [EPC] 6 0.0000
5 Platinum-based Drug [EPC] 5 0.0000
6 Vitamin D3 Analog [EPC] 1 0.0000
7 Kinase Inhibitor [EPC] 9 0.0000
8 Anti-IgE [EPC] 1 0.0000
9 Calcium [EPC] 2 0.0000
See all drug classes enriched for association with 5-HYDROXYINDOLACETIC ACID INCREASED